CTLA-4 polymorphisms and predisposition to digestive system malignancies: a meta-analysis of 31 published studies
- PMID: 32178688
- PMCID: PMC7077159
- DOI: 10.1186/s12957-020-1806-2
CTLA-4 polymorphisms and predisposition to digestive system malignancies: a meta-analysis of 31 published studies
Abstract
Background: The results of genetic association studies regarding cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) polymorphisms and digestive system malignancies were controversial. The authors designed this meta-analysis to more precisely estimate relationships between CTLA-4 polymorphisms and digestive system malignancies by pooling the results of related studies.
Methods: The authors searched PubMed, Embase, Web of Science, and CNKI for eligible studies. Thirty-one eligible studies were pooled analyzed in this meta-analysis.
Results: The pooled meta-analysis results showed that genetic distributions of rs231775, rs4553808, and rs733618 polymorphisms among patients with digestive system malignancies and controls differed significantly. Moreover, genotypic distribution differences were also observed for rs231775 polymorphism among patients with colorectal cancer/pancreatic cancer and controls, for rs4553808 and rs5742909 polymorphisms among patients with gastric cancer and controls, for rs3087243 polymorphism among patients with liver cancer and controls, and for rs733618 polymorphism among patients with colorectal cancer and controls in pooled meta-analyses.
Conclusions: This meta-analysis suggested that rs231775 polymorphism was associated with predisposition to colorectal cancer and pancreatic cancer, rs4553808 and rs5742909 polymorphisms were associated with predisposition to gastric cancer, rs3087243 polymorphism was associated with predisposition to liver cancer, and rs733618 polymorphism was associated with predisposition to colorectal cancer.
Keywords: Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4); Digestive system malignancies; Meta-analysis; Polymorphisms.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies.Cell Physiol Biochem. 2018;47(1):414-427. doi: 10.1159/000489953. Epub 2018 May 18. Cell Physiol Biochem. 2018. PMID: 29794444
-
Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis.Ann Hum Genet. 2018 Nov;82(6):358-369. doi: 10.1111/ahg.12262. Epub 2018 Jul 15. Ann Hum Genet. 2018. PMID: 30009380
-
The Association of CTLA-4 rs231775 and rs3087243 Polymorphisms with Latent Autoimmune Diabetes in Adults: A Meta-Analysis.Biochem Genet. 2022 Aug;60(4):1222-1235. doi: 10.1007/s10528-021-10152-w. Epub 2021 Nov 25. Biochem Genet. 2022. PMID: 34822071
-
Associations between cytotoxic T-lymphocyte-associated antigen 4 gene polymorphisms and diabetes mellitus: a meta-analysis of 76 case-control studies.Biosci Rep. 2019 May 15;39(5):BSR20190309. doi: 10.1042/BSR20190309. Print 2019 May 31. Biosci Rep. 2019. PMID: 30988065 Free PMC article.
-
Association of four CTLA-4 gene polymorphisms with pemphigus risk: a systematic review, meta-analysis, and meta-regression.J Int Med Res. 2024 Oct;52(10):3000605241282116. doi: 10.1177/03000605241282116. J Int Med Res. 2024. PMID: 39397428 Free PMC article.
Cited by
-
The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancer.World J Surg Oncol. 2021 Jul 16;19(1):215. doi: 10.1186/s12957-021-02325-z. World J Surg Oncol. 2021. PMID: 34271938 Free PMC article.
-
Immune Checkpoint Molecules-Inherited Variations as Markers for Cancer Risk.Front Immunol. 2021 Jan 14;11:606721. doi: 10.3389/fimmu.2020.606721. eCollection 2020. Front Immunol. 2021. PMID: 33519815 Free PMC article. Review.
-
Checkpoint Inhibitors in Melanoma Patients with Underlying Autoimmune Disease.Cancer Manag Res. 2021 Nov 2;13:8199-8208. doi: 10.2147/CMAR.S283217. eCollection 2021. Cancer Manag Res. 2021. PMID: 34754240 Free PMC article. Review.
-
Exploration of the association between the single-nucleotide polymorphism of co-stimulatory system and rheumatoid arthritis.Front Immunol. 2023 Jun 29;14:1123832. doi: 10.3389/fimmu.2023.1123832. eCollection 2023. Front Immunol. 2023. PMID: 37457686 Free PMC article.
-
Comprehensive Analysis of 29,464 Cancer Cases and 35,858 Controls to Investigate the Effect of the Cytotoxic T-Lymphocyte Antigen 4 Gene rs231775 A/G Polymorphism on Cancer Risk.Front Oncol. 2022 May 4;12:878507. doi: 10.3389/fonc.2022.878507. eCollection 2022. Front Oncol. 2022. PMID: 35600409 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources